A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Experts say a healthy vaginal microbiome may cut down one's risk of infections like HPV in check. Probiotics can balance pH, ...

The Department of Health (DOH) on Friday provided free cervical and breast cancer screening to public school teachers of ...

ATLANTA - Femasys Inc. (NASDAQ:FEMY), a biomedical company specializing in women's health, has announced the UK regulatory approval of three of its products: the FemaSeed Intratubal Insemination ...

“This is another key milestone as we expand our reach to the UK following successful approval across Europe for our innovative infertility and cancer detection products.” stated Kathy Lee-Sepsick, ...

Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive ...

The Health Ministry issued a statement on World Cancer Awareness Day, saying that this disease does not discriminate.

The Indonesian Government has prepared a National Action Plan to handle four priority cancers, including eradicating cervical ...

Source: Getty Images In 2025, an estimated 13,360 women will be diagnosed with cervical cancer, and 4,320 will die from the disease. Some strains of HPV are more likely to cause cancer.